White House announces IVF drug pricing deal for ‘TrumpRx’ site

EMD Serono will sell fertility drugs on the Trump direct-to-consumer marketplace. Trump also preview plans to encourage ...
CURE

FDA Fast Tracks NG-350A for Some With Advanced Rectal Cancer

NG-350A has received FDA fast track designation for mismatch repair-proficient locally advanced rectal cancer, addressing a ...

U.S. Widens Campaign Against Alleged Drug Boats With Eastern Pacific Strikes

Five people were killed in the attacks as the military targeted suspected trafficking in an area where large amounts of ...

Exclusive: Bill Gates, PAHO consider ways to bring weight-loss drugs to lower-income countries

The Gates Foundation and the Pan American Health Organization are both working on ways to make weight-loss drugs like Novo ...

U.S. Food and Drug Administration Awards Year Two Proceeds from Orphan Products Grant Supporting Palvella Therapeutics’ Phase 3 SELVA Trial of QTORIN™ Rapamycin for ...

Second year proceeds granted following FDA review of annual performance progress report on Phase 3 SELVA single-arm, baseline-controlled trial; ...

PMV Pharmaceuticals Announces Updated Rezatapopt Monotherapy Interim Data From Ongoing PYNNACLE Phase 2 Trial Across Multiple Solid Tumors With a TP53 Y220C Mutation

Data presented today as an oral presentation at 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics ...
Targeted Oncology

FDA Grants Fast Track to NG-350A for pMMR Rectal Cancer

FDA fast track designation for NG-350A aims to expedite its development for mismatch repair-proficient locally advanced ...
InSight Crime

Behind the Curtain: How Trump’s Spat With Colombia Could Impact Anti-Drug Ops

US anti-drug assistance to Colombia is fundamental and it will benefit no one to cut resources used to fight the cocaine ...

FDA approves new drug, cemiplimab, to help prevent recurring skin cancer

A significant advancement in skin cancer treatment has arrived. The US FDA has approved cemiplimab, known as Libtayo, to help prevent certain skin can ...

Palvella Therapeutics Inc.: U.S. Food and Drug Administration Awards Year Two Proceeds from Orphan Products Grant Supporting Palvella Therapeutics' Phase 3 SELVA Trial of ...

Second year proceeds granted following FDA review of annual performance progress report on Phase 3 SELVA single-arm, baseline-controlled trial; up to $2.6 million in non-dilutive funding anticipated ...